Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 125, pseudogene (RNU1-125P) is classified as a pseudogene of the U1 small nuclear RNA (snRNA) family[4][5]. Pseudogenes like RNU1-125P are genomic DNA sequences similar to normal genes but are generally non-functional due to accumulated mutations or lack of regulatory elements required for expression[4]. While canonical U1 snRNA genes play a critical role in pre-mRNA splicing as part of the spliceosome complex, binding the 5'-splice site and initiating spliceosome assembly, pseudogenes such as RNU1-125P do not produce functional snRNAs[1][4]. According to current knowledge and gene databases, there is no evidence that RNU1-125P is transcribed or that it has a role in gene regulation, disease, or as a therapeutic target. No interacting drugs, biomarkers, or disease associations are known for this pseudogene, and its only recognized significance is as a genomic relic of ancestral U1 snRNA gene duplications[4][5]. Key notes: - RNU1-125P is a pseudogene; it is not considered an active gene, enzyme, receptor, or drug target[4][5]. - There is nothing to indicate direct therapeutic relevance or clinical importance for this gene in current biomedical resources[4][5]. - The entry is correct as named, but functionally not a target; the only potential issue is if a user expected a functional protein or RNA rather than a pseudogene. Explanation for fields: - "is_incorrect" is marked **true** because RNU1-125P is not a receptor, enzyme, transporter, etc., nor is it a functional target or active regulatory RNA. It is simply a pseudogene with no known biological activity[4][5]. - Nearly all fields regarding function, disease roles, or therapeutics are **null** because pseudogenes do not typically have such attributes. - Molecular classification marks it as "Other" (pseudogene, non-coding RNA). - Description summarizes that this is not a functional molecule or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 125, pseudogene (RNU1-125P).